Clinical outcomes of transarterial chemoembolization combined with durvalumab for advanced and metastatic biliary tract cancer

Background This study aimed to evaluate the safety and efficacy of TACE combined with durvalumab for treating advanced and metastatic BTC. Research design and methods: Data were collected retrospectively from a single center. The TACE procedures were performed 1 to 19 times, with repetitions occurri...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yuefeng Hu, Jian Wei, Xuedong Sun, Guang Chen, Tianhao Su, Zeran Yang, Xu Lu, Long Jin
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2025-12-01
Serie:	Future Science OA
Soggetti:	Biliary tract cancer immune checkpoint inhibitors transarterial chemoembolization durvalumab Immunotherapy
Accesso online:	https://www.tandfonline.com/doi/10.1080/20565623.2025.2526947
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!